lifestyle.projectdiaspora.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Caribou Biosciences, Inc.
Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference
May 6, 2026
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
May 2, 2026
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
April 28, 2026
Caribou Biosciences to Participate in Upcoming Investor Conferences
February 12, 2026
Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR®
February 10, 2026